Goldstuck Norman D, Steyn Petrus S
Department of Obstetrics and Gynaecology, Tygerberg Hospital, Western Cape 7505, South Africa.
Reproductive Health and Fertility Regulation, Department of Obstetrics and Gynaecology, Groote Schuur Hospital and University of Cape Town, Cape Town 7925, South Africa.
ISRN Obstet Gynecol. 2013 Dec 11;2013:814062. doi: 10.1155/2013/814062.
Background. Women with diabetes mellitus type I and type II need effective contraception for personal and medical reasons. Long acting reversible contraceptive (LARC) methods are among the most efficient and cost-effective methods. Study Design. We searched the Popline, PubMed, and clinicaltrials.gov databases from 1961 to March 2013 for studies on the efficacy of the IUD in diabetic women and the possible changes it may produce in laboratory parameters. Studies of at least 30 subjects with DM1 or DM2 who were studied for 6 to 12 months depending on the method of analysis were eligible. Results. The search produced seven articles which gave event rate efficacy evaluable results and three which evaluated the effect of the IUD on laboratory parameters. One of the earlier efficacy studies showed an abnormally high pregnancy rate which sparked a controversy which is discussed in the Introduction section. The remaining 6 studies produced acceptable pregnancy rates. The three laboratory studies showed that the copper and levonorgestrel releasing IUD/IUS do not affect the diabetic state in any way. Conclusions. The copper bearing and levonorgestrel releasing IUDs are safe and effective in women with diabetes type I and diabetes type II although the evidence in the latter is limited.
背景。出于个人和医学原因,I型和II型糖尿病女性需要有效的避孕措施。长效可逆避孕(LARC)方法是最有效且性价比最高的方法之一。研究设计。我们检索了1961年至2013年3月的Popline、PubMed和clinicaltrials.gov数据库,以查找关于宫内节育器(IUD)在糖尿病女性中的疗效以及其可能引起的实验室参数变化的研究。符合条件的研究为至少30名1型糖尿病(DM1)或2型糖尿病(DM2)患者,根据分析方法进行6至12个月的研究。结果。检索得到7篇给出事件率疗效可评估结果的文章,以及3篇评估IUD对实验室参数影响的文章。早期的一项疗效研究显示妊娠率异常高,引发了一场争议,在引言部分进行了讨论。其余6项研究得出了可接受的妊娠率。3项实验室研究表明,含铜和释放左炔诺孕酮的宫内节育器/系统对糖尿病状态没有任何影响。结论。含铜和释放左炔诺孕酮的宫内节育器对I型糖尿病和II型糖尿病女性是安全有效的,尽管后者的证据有限。